Barrier Measures to Limit Covid-19.Nosocomial Transmission: a Cross-sectional Evaluation

NCT ID: NCT04376944

Last Updated: 2020-05-06

Basic Information

• Recruitment Status: UNKNOWN
• Total Enrollment: 300 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2020-04-01
• Study Completion Date: 2020-12-30

Brief Summary

Use lay language. The Covid-19 pandemic hit France in March 2020 and stage 3 of the epidemic justified the introduction of national and unprecedented containment measures from March 17, 2020. The Montpellier CHU experienced peak hospitalizations of Covid-19 infections in late March. The estimate of the proportion of infected people in Occitania, South of France, for the 11th of May 2020 is 3.1% (95% CI: 1.9-5.9) for the Occitania region, to which Montpellier belongs.

In the context of the Covid-19 epidemic, notably due to the absence of pharmacological or vaccine prophylaxis, barrier measures were of crucial importance, especially for exposed caregivers. These measures include an adaptation of individual behavior, the creation of a so-called "Covid" hospital, the wearing of specific equipment in all departments, the use in the rooms of Covid-19 patients of a gown, an apron, gloves, and a FFP2 type mask in the event of contact and sampling, protocolized and standardized bio-cleaning measures, a reorganization of the premises and the definition of specific circuits.

In view of the second wave of the epidemic, estimating the effectiveness of the barrier measures is of major importance. The investigators therefore propose an evaluation of the effectiveness of these measures, by comparing the serological prevalence of infection among caregivers working directly in COVID units compared to caregivers working in services excluding the management of Covid-19 patients.

Systematic evaluation in COVID-19 units of Sarc-Co-V2 infection will also be assessed, with naso-pharyngeal swabs.

Conditions

Caregivers; COVID-19

Study Design

• Observational Model Type: CASE_CONTROL
• Study Time Perspective: CROSS_SECTIONAL

Study Groups

Exposed group

Caregivers and agents working directly in COVID units compared to those living.

Survey

Intervention Type: OTHER

questionnaire on their symptoms and their exposures

Control group

caregivers anf agents working in services excluding the management of patients screened positive for Covid-19 infection

Survey

Intervention Type: OTHER

questionnaire on their symptoms and their exposures

Interventions

Survey

questionnaire on their symptoms and their exposures

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• exposed group: exposed caregivers and agents who worked in COVID units (medicine, resuscitation, screening) until their date of collection. An exposed agent or caregiver is defined by the entrance of rooms with a COVID-19 infection during their professional activity.
• low or unexposed group: caregivers or agents who have worked in non-COVID units in a non-COVID hospital

Exclusion Criteria

• refusal to participate

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

University Hospital, Montpellier

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Marie Bistoquet, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Montpellier

Locations

Uh Montpellier

Montpellier, , France

Site Status: RECRUITING

Countries

France

Central Contacts

Alain MAKINSON, MCU-PH

Role: CONTACT

a-makinson@chu-montpellier.fr

0663075260 ext. 33

Marie Bistoquet, MD

Role: CONTACT

m-bistoquet@chu-montpellier.fr

Facility Contacts

Marie Bistoquet, MB

Role: primary

m-bistoquet@chu-montpellier.fr

Other Identifiers

RECHMPL20_0261

Identifier Type: -

Identifier Source: org_study_id